Skip to main content
Download PDF

District-level strategies to control the HIV epidemic in Zimbabwe: a practical example of precision public health

BMC Research Notes volume 13, Article number: 393 (2020) Cite this article

Abstract

Objective

We conducted a descriptive cross-sectional study using survey and programme data to assess district-level performance along the HIV care cascade (HIV testing target achievement, linkage to ART and ART coverage) in order to formulate district-specific recommendations, taking into consideration prevalence and yield of testing.

Results

Data from 60 districts were analysed. Forty-eight districts (80.0%) surpassed 90% of their 2018 HIV testing targets. Linkage to ART was less than 90% in 40 districts (83.3%). Thirty districts (50.0%) had ART coverage above 90%. Of the 30 districts with suboptimal (< 90%) ART coverage, 18 districts had achieved high HIV testing target but with suboptimal linkage to ART, 6 had achieved high HIV testing targets and high linkage to ART, 4 had both suboptimal HIV testing target achievement and linkage to ART and 2 had suboptimal HIV testing target achievement and high linkage to ART. Priority should be given to districts with suboptimal ART coverage. Remediation strategies should be tailored to address the poorly performing stage of the cascade in each of the districts.

Introduction

In 2019, Zimbabwe had about 1.2 million [95% confidence interval (CI): 1.1–1.4 million] people living with HIV (PLHIV) [1]. The number of new HIV infections decreased by 35.3%, from 62 000 [95% CI 45 000–83 000] to 38 000 [95% CI 28 000–51 000] between 2010 and 2018. HIV-related deaths also decreased by 42.6%, from 54,000 [95% CI 43,000–68,000] to 22,000 [95% CI 17,000–27 000] during the same period [1]. The Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA) survey, conducted in 2015–2016 to assess progress towards the UNAIDS 90-90-90 targets [2], showed that 74.2% of all PLHIV reported knowing their HIV status, of whom 86.8% were on antiretroviral therapy (ART) and 86.5% of those on ART were virally suppressed [3].

Most countries show national data, without evidence on whether this mirrors the data at sub-national levels. Hence, most national programmes, including those in Zimbabwe, do not provide recommendations adapted for district-level indicators. At the same time, donors call for targeted and cost-effective strategies, due to dwindling funds [4, 5]. Advances in information technology provide an opportunity for data-driven health interventions. In our study, we combined mapping data on HIV prevalence [6] with data from the Zimbabwe National ART Program 2018. We studied the district-level performance along the HIV care cascade (HIV testing target achievement, linkage to ART and ART coverage) and formulated district-level recommendations considering HIV prevalence and HIV testing yield.

Main text

Methods

We conducted a descriptive cross-sectional study and retrieved the district-level HIV prevalence from the mapping study [6].

For each district, the number of people tested and the number tested positive and initiated on ART in 2018, and the total number of clients on ART at the end of 2018 were obtained from the Ministry of Health and Child Care (MoHCC), District Health Information System 2 (DHIS 2) [7]. Permission was obtained from the relevant authorities.

To estimate the district-level HIV testing achievement in 2018, we first calculated the district-level targets. We calculated the percentage of PLHIV in every district by dividing the estimated number of PLHIV in a district with the estimated total number of PLHIV in the country in 2018. We then use this percentage to distribute the overall national HIV testing target for 2018 to the districts [8, 9]. Second, we calculated the testing coverage by dividing the number of tests conducted with the district target (number of tests proposed by each district) [10]. The HIV testing yield was calculated by dividing the number of positive tests with the number of tests conducted per district.

Linkage to ART was estimated by dividing the number of patients that were started on ART in 2018 with the number of positive tests in the same year (with the assumption that under the World Health Organization’s HIV “Treat All” recommendations, all those tested positive had been put on ART [11]). The ART coverage was estimated by dividing the number of patients reported as active on ART at the end of 2018 in a district with the total number of PLHIV in that district.

HIV testing target achievement, linkage to ART and ART coverage were categorised into low (< 70%), medium (70–90%) and high (> 90%) and the district-level categorisation was visualized on maps using geographic information systems (GIS).

We also described district-level performance along the HIV cascade for those districts with suboptimal (< 90%) ART coverage. These were grouped as follows: 1. Suboptimal HIV testing target achievement/suboptimal linkage to ART, 2. Suboptimal HIV testing target achievement/high linkage to ART, 3. High HIV testing target achievement/suboptimal linkage to ART and 4. High HIV testing target achievement/high linkage to ART.

Results

We included all the districts of Zimbabwe in the analysis. District-level categorization of HIV prevalence, HIV testing target achievement, linkage to ART and ART coverage are shown in Fig. 1.

Fig. 1
figure 1

Maps showing; a HIV prevalence, b HIV testing target achievement, c linkage to ART, d ART coverage

Full size image

The highest prevalence was in Bubi District (21.5%) followed by Bulilima District (20.8%) and Tsholotsho District (20.7%). Forty-eight districts (80.0%) surpassed 90% of their 2018 HIV testing target. Only three reported a low (< 70%) testing coverage: Insiza (69.2%), Chikomba (62.7%) and Umzingwane (62.5%). A total of 29 districts (48.3%) had an HIV testing yield between 5.0 and 7.5% (Additional file 1: Figure S1). Linkage to ART was less than 90% in 40 districts (83.3%).

Thirty districts (50.0%) had high ART coverage (> 90%). Of the 30 districts with suboptimal coverage, 24 districts (40.0%) had medium coverage (70–90%), while the ART coverage was low (< 70%) in 6 districts (10.0%): Gokwe North (39.4%), Gokwe South (44.4%), Umguza (49.7%), Centenary (61.0%), Uzumba-Maramba-Pfungwe (63.0%) and Binga (68.0%).

Table 1 shows the district-level performance along the HIV cascade among 30 districts with suboptimal ART coverage (< 90%). Of the 30 districts, 4 had both suboptimal HIV testing target achievement and linkage to ART, 18 had high HIV testing target achievement but suboptimal linkage to ART, 6 had high HIV testing target achievement and high linkage to ART and 2 had suboptimal HIV testing coverage but high linkage to ART.

Table 1 HIV cascade for 30 districts with suboptimal (< 90%) ART coverage in 2018, Zimbabwe
Full size table

Discussion

In Zimbabwe, half of the districts had high (> 90%) ART coverage, and thus had achieved the second target of the UNAIDS 90-90-90 targets [2]. However, substantial within-country variations in terms of HIV prevalence, HIV testing coverage, HIV testing yield, linkage to ART and ART coverage were observed. We have proposed four categories of districts according to gaps along the HIV cascade, for which district-specific recommendations can be formulated.

Suboptimal HIV testing target achievement and suboptimal linkage to ART

In the four districts with both suboptimal HIV testing achievement and linkage to ART, both the HIV prevalence and the HIV testing yield were above average, highlighting an important unmet need for HIV testing services. Therefore, HIV testing services should become more widely available. It has been seen that widespread door-to-door HIV testing substantially increases the acceptance of HIV testing and should be considered as a priority [12]. In addition, strategies linking those who tested positive to ART should be strengthened (elaborated below).

High testing target achievement and suboptimal linkage to ART

Eighteen districts with suboptimal ART coverage that achieved their HIV testing target but with suboptimal linkage to ART should assess if strategies known to improve linkage to care and ART initiation are in place. These strategies include same-day ART initiation, community (home-based) ART initiation, decentralisation of ART services to the primary health care level and integration of HIV care in other health care services [13,14,15,16,17]. Linkage to ART should be regularly assessed at the health facility level. Those who are diagnosed with HIV but have not been started on ART should be tracked. Consent for tracking should be incorporated into the testing strategy [18]. Patients diagnosed at higher-level referral health facilities should be initiated on ART before down referral to lower-level health facilities for follow up, with tracking of arrival after referral [19]. Some districts may have specific challenges. Poor linkage to ART around Kwekwe and the surrounding districts might be explained by the presence of illegal artisanal miners in the region. Illegal artisanal miners are highly mobile, and strategies to link and retain these highly mobile populations should be identified [20, 21]. Also, in districts bordering Zambia and Mozambique (Centenary, Mudzi and Nyanga), the poor linkage may be due to patients crossing the border as a result of the economic challenges in Zimbabwe. The Southern African Development Community (SADC) HIV and AIDS Cross Border Initiative should be fully implemented to enable the provision of care and tracking of such patients [22,23,24].

High testing target achievement and high linkage to ART

Six districts with suboptimal ART coverage achieved their HIV testing targets and had high linkage to ART. In such a scenario, other indicators may assist in the formulation of a district-specific strategy. If the prevalence and HIV testing yield are lower than average, HIV testing may need to be delivered in a more targeted manner. Health facility-based strategies in combination with community testing in high-risk groups may be most efficient. Health facility-based strategies that have worked elsewhere include index case testing, targeting sexual partners and HIV-exposed infants and intensified provider-initiated testing and counselling (IPITC) [25,26,27,28,29,30,31]. Community testing should prioritise subgroups with a higher prevalence. Key populations and hotspots identified from a mapping exercise conducted in Zimbabwe may guide programming [32]. Social network testing, using peer educators, can be a useful tool to reach some of the key populations [30].

Suboptimal HIV testing target achievement and high linkage to ART

There were two districts with suboptimal ART coverage that had suboptimal HIV testing target achievement but with high linkage to ART. In both, the HIV prevalence and testing yield were higher than average. Hence, HIV testing strategies recommended for high prevalence settings, discussed above, should be considered.

In conclusion, there is substantial within-country variation in terms of HIV prevalence, HIV testing target achievement, HIV testing yield, linkage to ART and ART coverage. Hence, a “one size fits all” approach is unlikely to result in achieving the next UNAIDS 95-95-95 targets by the end of 2030. District-level mapping of uncovered needs and gaps along the HIV cascade of care is needed, particularly for districts with suboptimal ART coverage.

Limitations

Our study is among the first to assess the performance across the HIV care cascade at the sub-national level. To validate our findings, we compared data from a variety of sources. However, there are limitations due to the cross-sectional design of our study. Crossover of patients between prior or later years with 2018 may have occurred, for instance, when patients diagnosed in 2017 started ART in 2018, and those diagnosed in 2018 started ART in 2019. The district HIV testing targets were calculated by using the percentage of the number of PLHIV per district to distribute the national HIV testing target without considering the context and performance of each district cascade of care. The MoHCC have since started estimating district yearly HIV testing targets by taking into consideration the context and district-specific parameters. Moreover, district-level data on the third “90” from the UNAIDS 90-90-90 targets, i.e. viral suppression, was unavailable. Previous studies showed that the retention on ART was high, while access to viral load monitoring and viral load suppression remained suboptimal [33,34,35].

Availability of data and materials

Zimbabwe data on HIV prevalence and the number of PLHIV is publicly available at http://ghdx.healthdata.org/ihme-data/africa-hiv-prevalence-geospatialestimates-2000–2017. The data from the Ministry of Health and Child Care on the number on ART per district by the end of 2018 is not available in the public domain. Anyone interested in using the data for scientific purpose is free to request permission from the Director of the AIDS and TB Program, AIDS and TB Unit, Ministry of Health and Child Care, Government of Zimbabwe, 2nd Floor, Mukwati Building, Harare, Zimbabwe. Email: atp.director@ymail.com

Abbreviations

CI:

Confidence interval

MoHCC:

Ministry of Health and Child Care

HIV:

Human Immunodeficiency Virus

AIDS:

Acquired Immunodeficiency Syndrome

ART:

Antiretroviral therapy

PLHIV:

People living with HIV

IPITC:

Intensified Provider Initiated Testing and Counselling

UNAIDS:

Joint United Nations Programme on HIV/AIDS

References

  1. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data. 2019. https://www.unaids.org/en/resources/documents/2019/2019-UNAIDS-data. Accessed 26 July 2020.

  2. Joint United Nations Programme on HIV/AIDS (UNAIDS). 90-90-90–An ambitious treatment target to help end the AIDS epidemic. 2014. https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf. Accessed 26 July 2020.

  3. Ministry of Health and Child Care (MOHCC)–Zimbabwe. Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) 2015–2016: First Report. 2017. https://phia.icap.columbia.edu/countries/zimbabwe/; https://phia.icap.columbia.edu/wp-content/uploads/2017/11/ZIMPHIA_First_Report_FINAL.pdf. Accessed 26 July 2020.

  4. The United States President’s Emergency Plan for AIDS Relief (PEPFAR). 2019 Annual Report to Congress. 2019. https://www.state.gov/wp-content/uploads/2019/09/PEPFAR2019ARC.pdf. Accessed 26 July 2020.

  5. Médecins Sans Frontières. Urgent boost and reality check needed for HIV and TB funding. 2019. https://www.msf.org/urgent-boost-and-reality-check-needed-hiv-and-tb-funding. Accessed 26 July 2020.

  6. Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, Mayala BK, VanderHeide JD, Collison ML, Hall JB, et al. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570(7760):189–93. https://doi.org/10.1038/s41586-019-1200-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ministry of Health and Child Care (MOHCC)–Zimbabwe: National Programme ART Summary. 2018.

  8. Ministry of Health and Child Care (MOHCC)–Zimbabwe. Extended Zimbabwe National AIDS Strategic Plan III (ZNASP III). 2020. http://nac.org.zw/wp-content/uploads/2019/01/Extended-Zimbabwe-National-AIDS-Strategic-Plan-3.pdf. Accessed 26 July 2020.

  9. Ministry of Health and Child Care (MOHCC)–Zimbabwe: Zimbabwe National HIV Estimates 2015. Harare, Zimbabwe. 2015.

  10. European Centre for Disease Prevention and Control (ECDC). Thematic report: Continuum of HIV care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC. 2017. https://ecdc.europa.eu/sites/portal/files/documents/Continuum-of-HIV-care-2017.pdf. Accessed 26 July 2020.

  11. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland. 2016. https://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf?sequence=1. Accessed 26 July 2020.

  12. World Health Organization. Guidelines on HIV self-testing and partner notification–Supplement to consolidated guidelines on HIV testing services. 2016. https://apps.who.int/iris/bitstream/handle/10665/251655/9789241549868-eng.pdf?sequence=1. Accessed 26 July 2020.

  13. Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A, Glass TR. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial. JAMA. 2018. https://doi.org/10.1001/jama.2018.1818.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67. https://doi.org/10.1097/QAD.0b013e3283578b9b.

    Article  CAS  PubMed  Google Scholar 

  15. Decroo T, Rasschaert F, Telfer B, Remartinez D, Laga M, Ford N. Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review. Int Health. 2013;5(3):169–79. https://doi.org/10.1093/inthealth/iht016.

    Article  PubMed  Google Scholar 

  16. MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, Butterworth AE, van Oosterhout JJ, Desmond N, Thindwa D, et al. Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA. 2014;312(4):372–9. https://doi.org/10.1001/jama.2014.6493.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Giordano TP. Strategies for linkage to and engagement with care: focus on intervention. Top Antivir Med. 2018;26(2):62–5.

    PubMed  PubMed Central  Google Scholar 

  18. Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, Mwafilaso J, Munthali C, Gupta S, Bateganya M, Maida A. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS ONE. 2018. https://doi.org/10.1371/journal.pone.0188488.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Decroo T, Panunzi I, das Dores C, Maldonado F, Biot M, Ford N, Chu K. Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. J Int AIDS Soc. 2009;12:6. https://doi.org/10.1186/1758-2652-12-6.

  20. Joint United Nations Programme on HIV/AIDS (UNAIDS), International Organization for Migration (IOM). Mobile Populations and HIV/AIDS in the Southern African Region. 2003. https://publications.iom.int/system/files/pdf/hiv_southafrica1.pdf. Accessed 26 July 2020.

  21. Taylor BS, Garduno LS, Reyes EV, Valino R, Rojas R, Donastorg Y, Brudney K, Hirsch J. HIV care for geographically mobile populations. Mt Sinai J Med. 2011;78(3):342–51. https://doi.org/10.1002/msj.20255.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Vearey J. Moving forward: why responding to migration, mobility and HIV in South(ern) Africa is a public health priority. J Int AIDS Soc. 2018. https://doi.org/10.1002/jia2.25137.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Southern African Development Community (SADC). Statement of SADC Ministers of Health and Ministers Responsible for HIV and AIDS Meet in Namibia 8th November 2018. 2018. https://www.sadc.int/files/3315/4169/8409/Media_Statement_-_Joint_Meeting_of_SADC_Ministers_of_Health_and_those_responsible_for_HIV_and_AIDS_.pdf. Accessed 26 July 2020.

  24. Southern African Development Community (SADC). SADC HIV and AIDS Cross Border Initiative. 2013. https://www.comminit.com/africa/content/sadc-hiv-and-aids-cross-border-initiative. Accessed 26 July 2020.

  25. Lasry A, Medley A, Behel S, Mujawar MI, Cain M, Diekman ST, Rurangirwa J, Valverde E, Nelson R, Agolory S, et al. Scaling Up Testing for Human Immunodeficiency Virus Infection Among Contacts of Index Patients—20 Countries, 2016–2018. MMWR. 2019;68:21:474–7. doi:http://dx.doi.org/10.15585/mmwr.mm6821a2; https://www.cdc.gov/mmwr/volumes/68/wr/mm6821a2.htm.

  26. Jubilee M, Park FJ, Chipango K, Pule K, Machinda A, Taruberekera N. HIV index testing to improve HIV positivity rate and linkage to care and treatment of sexual partners, adolescents and children of PLHIV in Lesotho. PLoS ONE. 2019;14(3):e0212762. https://doi.org/10.1371/journal.pone.0212762.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ahmed S, Sabelli RA, Simon K, Rosenberg NE, Kavuta E, Harawa M, Dick S, Linzie F, Kazembe PN, Kim MH. Index case finding facilitates identification and linkage to care of children and young persons living with HIV/AIDS in Malawi. Trop Med Int Health. 2017;22(8):1021–9. https://doi.org/10.1111/tmi.12900.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Mahachi N, Muchedzi A, Tafuma TA, Mawora P, Kariuki L, Semo BW, Bateganya MH, Nyagura T, Ncube G, Merrigan MB, et al. Sustained high HIV case-finding through index testing and partner notification services: experiences from three provinces in Zimbabwe. J Int AIDS Soc. 2019. https://doi.org/10.1002/jia2.25321.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Sharma M, Smith JA, Farquhar C, Ying R, Cherutich P, Golden M, Wamuti B, Bukusi D, Spiegel H, Barnabas RV. Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya. AIDS. 2018;32(2):233–41. https://doi.org/10.1097/QAD.0000000000001697.

    Article  PubMed  PubMed Central  Google Scholar 

  30. ICAP; Columbia University–Mailman School of Public Health. ICAP Approach to Strategic HIV Testing. 2017. https://icap.columbia.edu/wp-content/uploads/ICAP_Approach_to_Strategic_HIV_Testing_20Julyl17.pdf. Accessed 26 July 2020.

  31. Kayigamba FR, Van Santen D, Bakker MI, Lammers J, Mugisha V, Bagiruwigize E, DeNaeyer L, Asiimwe A, Van Der Loeff MF. Does provider-initiated HIV testing and counselling lead to higher HIV testing rate and HIV case finding in Rwandan clinics? BMC Infect Dis. 2016;16:26. https://doi.org/10.1186/s12879-016-1355-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Zimbabwe National AIDS Council, Zimbabwe Ministry of Health and Child Welfare, UNAIDS, World Food Programme VAM Food Security Analysis, CDC. Smart investment to end HIV/AIDS in Zimbabwe based on hotspot analysis. 2015. https://procurement-notices.undp.org/view_file.cfm?doc_id=114244. Accessed 26 July 2020.

  33. Makurumidze R, Mutasa-Apollo T, Decroo T, Choto RC, Takarinda KC, Dzangare J, Lynen L, Van Damme W, Hakim J, Magure T, et al. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015. PLoS ONE. 2012. https://doi.org/10.1371/journal.pone.0222309.

    Article  Google Scholar 

  34. The United States President’s Emergency Plan for AIDS Relief (PEPFAR). Zimbabwe Country Operational Plan (COP/ROP) 2018 Revised Strategic Direction Summary. 2018. https://www.pepfar.gov/documents/organization/285847.pdf. Accessed 26 July 2020.

  35. Ministry of Health and Child Care (MOHCC) - Zimbabwe. Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) 2015–2016: Final Report. 2019. https://phia.icap.columbia.edu/countries/zimbabwe/; https://phia.icap.columbia.edu/wp-content/uploads/2019/08/ZIMPHIA-Final-Report_integrated_Web-1.pdf. Accessed 26 July 2020.

Download references

Acknowledgements

The authors of the articles would like express gratitude and appreciation to Lindgren et al. (2019) from the Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA for the permission to use Zimbabwe data on HIV prevalence and number of PLHIV and the Ministry of Health and Child care for providing data on the number on ART per district by the end of 2018.

Funding

Richard Makurumidze receives a PhD scholarship grant from the Institute of Tropical Medicine, Antwerp, Belgium funded by the Belgian Development Cooperation (DGD). The funder had no role in the design of the study; collection, analysis, and interpretation of data and in the writing of the manuscript.

Author information

Authors and Affiliations

  1. College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe

    Richard Makurumidze, James Hakim & Simbarashe Rusakaniko

  2. Institute of Tropical Medicine, Antwerp, Belgium

    Richard Makurumidze, Tom Decroo, Lutgarde Lynen & Wim Van Damme

  3. Research Foundation of Flanders, Brussels, Belgium

    Tom Decroo

  4. Gerontology, Faculty of Medicine & Pharmacy, Free University of Brussels (VUB), Brussels, Belgium

    Richard Makurumidze & Wim Van Damme

  5. Ministry of Health and Child Care, Geographic Information System Department, Harare, Zimbabwe

    Zororo Kudzaishe Chinwadzimba

Authors
  1. Richard Makurumidze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom Decroo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lutgarde Lynen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zororo Kudzaishe Chinwadzimba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wim Van Damme
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James Hakim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Simbarashe Rusakaniko
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RM led the conceptualisation of the paper, data analysis and writing of the original draft paper. ZKC developed the maps. TD, LL, ZKC, VWD, JH and SR reviewed all sections of the manuscript. All authors contributed to interpreting the data and editing of the paper, and all approved the final version. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Richard Makurumidze.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Figure S1.

Yield per district among HIV tests performed in 2018 in Zimbabwe.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Makurumidze, R., Decroo, T., Lynen, L. et al. District-level strategies to control the HIV epidemic in Zimbabwe: a practical example of precision public health. BMC Res Notes 13, 393 (2020). https://doi.org/10.1186/s13104-020-05234-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13104-020-05234-8

Keywords

BMC Research Notes

ISSN: 1756-0500

Contact us